Darlene Noci - Dec 18, 2023 Form 4 Insider Report for Nuvalent, Inc. (NUVL)

Role
Chief Development Officer
Signature
/s/ Deborah A. Miller, attorney-in-fact
Stock symbol
NUVL
Transactions as of
Dec 18, 2023
Transactions value $
-$2,844,661
Form type
4
Date filed
12/20/2023, 04:56 PM
Previous filing
Nov 3, 2023
Next filing
Jan 9, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction NUVL Class A Common Stock Options Exercise $24.4K +22.6K $1.08* 22.6K Dec 18, 2023 Direct
transaction NUVL Class A Common Stock Options Exercise $79.6K +11.6K +51.15% $6.89* 34.2K Dec 18, 2023 Direct
transaction NUVL Class A Common Stock Options Exercise $84.1K +5.84K +17.09% $14.40 40K Dec 18, 2023 Direct
transaction NUVL Class A Common Stock Sale -$3.03M -40K -100% $75.82 0 Dec 18, 2023 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction NUVL Stock Option (Right to Buy) Options Exercise $0 -22.6K -32.85% $0.00 46.2K Dec 18, 2023 Class A Common Stock 22.6K $1.08 Direct F2
transaction NUVL Stock Option (Right to Buy) Options Exercise $0 -11.6K -43.87% $0.00 14.8K Dec 18, 2023 Class A Common Stock 11.6K $6.89 Direct F3
transaction NUVL Stock Option (Right to Buy) Options Exercise $0 -5.84K -11.68% $0.00 44.2K Dec 18, 2023 Class A Common Stock 5.84K $14.40 Direct F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $75.40 to $76.36, inclusive. The reporting person undertakes to provide to the staff of the Securities and Exchange Commission, Nuvalent, Inc. or any security holder of Nuvalent, Inc., upon request, full information regarding the number of shares sold at each separate price.
F2 The shares underlying this option vest as follows: 25% of the shares vested on January 11, 2022, and the remainder have vested or shall vest over the next three years thereafter in equal monthly installments, subject to continued service to Nuvalent, Inc. through the applicable vesting date.
F3 The shares underlying this option vest as follows: 25% of the shares vested on April 29, 2022, and the remainder have vested or shall vest over the next three years thereafter in equal monthly installments, subject to continued service to Nuvalent, Inc. through the applicable vesting date.
F4 The shares underlying this option vest as follows: 25% of the shares vested on August 1, 2023, and the remainder have vested or shall vest over the next three years in equal monthly installments, subject to continued service to Nuvalent, Inc. through the applicable vesting date.